← Back to Clinical Trials
Recruiting NCT07287774

NCT07287774 Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07287774
Status Recruiting
Phase
Sponsor Purdue University
Condition Hearing Loss, Cochlear
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-10-16
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Hearing Aid Noise Reduction - OffHearing Aid Noise Reduction - LowHearing Aid Noise Reduction - High

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-10-16 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed to understand how different hearing-aid noise-reduction technologies affect a listener's ability to hear speech in noisy environments. Participants will listen to speech at several background-noise levels while trying different processing settings. By comparing performance across these conditions, the study aims to identify which types of noise reduction improve speech intelligibility the most. We expect that some noise-reduction strategies will help listeners understand speech better than others, especially in more difficult listening situations.

Eligibility Criteria

Inclusion Criteria: * A hearing aid candidate with mild-to-moderate cochlear hearing loss, based on audiometric profile (at least 20 dB of hearing loss at 2000 Hz, with progressively worse hearing levels at higher frequencies). Exclusion Criteria: * Normal hearing * Severe or profound hearing loss * Conductive hearing loss * Neural hearing loss

Frequently Asked Questions

Who can join the NCT07287774 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hearing Loss, Cochlear. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07287774 currently recruiting?

Yes, NCT07287774 is actively recruiting participants. Visit ClinicalTrials.gov or contact Purdue University to inquire about joining.

Where is the NCT07287774 trial being conducted?

This trial is being conducted at West Lafayette, United States.

Who is sponsoring the NCT07287774 clinical trial?

NCT07287774 is sponsored by Purdue University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology